WILMINGTON, Del. & MUNICH--(BUSINESS WIRE)--JenaValve™ Technology, Inc., a medical device company specializing in developing transcatheter valve implantation systems, today announced that it has completed First-in-Man (FIM) procedures for its transapical transcatheter aortic valve implantation (TAVI) system. The procedures and implantations were successfully performed in nine patients at the Heart Center, Leipzig, Germany.
